How to Buy Bicara Therapeutics Stock
Bicara Therapeutics Inc
Bicara Therapeutics Inc. , a clinical-stage biopharmaceutical company, develops bifunctional therapies for solid tumors.
Bicara Therapeutics stock last closed at $23.11, down 1.53% from the previous day, and has increased 82.69% in one year. It has overperformed other stocks in the Biotechnology industry by 0.86 percentage points. Bicara Therapeutics stock is currently +196.28% from its 52-week low of $7.80, and -4.7% from its 52-week high of $24.25.
As of Apr 21, 2026, there are 65.47M BCAX shares outstanding. The market cap of BCAX is $1.51B. In the past 24 hours, 605,000 BCAX shares were traded.
How to Buy Bicara Therapeutics Stock
Not sure how to invest in Bicara Therapeutics stock? Here's how.
- Figure out where to buy Bicara Therapeutics stock: You need to pick a stock brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you choose where to buy Bicara Therapeutics stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Deposit money your brokerage account: Select your payment method and add your details.
- Analyze Bicara Therapeutics stock: The Bicara Therapeutics ticker symbol is BCAX. Is Bicara Therapeutics stock a good investment? Should you buy shares of BCAX? How do BCAX's underlying business fundamentals look? Do top analysts think Bicara Therapeutics is a good buy? Why has BCAX's stock price moved recently? (Hint: Our stock market analysis tools can help you understand if BCAX is a good stock to buy).
- Execute your BCAX purchase: Decide if you will purchase BCAX shares at the current market price or use a limit order to purchase BCAX shares at a given price.
- Get key alerts regarding your BCAX position: Create a watchlist to keep track of your investment in Bicara Therapeutics shares.
Step 1: Figure out where to buy Bicara Therapeutics stock
You need an online brokerage account to access the NASDAQ market and buy BCAX stock.
Our favorite brokerage: eToro
In our opinion, eToro is the best stock brokerage. eToro gives you:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to global markets: From Technology to Industrials, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro offers a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've picked the best brokerage, it's time to fill out some personal info so you are able to invest in BCAX stock today.
How to Set Up a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to start your new brokerage account.
- Submit your info by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you've created your account on the best stock market app, you need to deposit funds:
Check out the walkthrough below to see the process of transferring funds into your investment account.
Step 4: Analyze Bicara Therapeutics stock
Once you have selected the best place to buy Bicara Therapeutics stock, it's critical to evaluate their stock prior to investing, so you can wrap your head around the risk and upside.
Bicara Therapeutics stock data
Bicara Therapeutics Due Diligence Checks
WallStreetZen was built to help average investors do more accurate fundamental analysis quickly.
You can view all of the due diligence checks on BCAX's stock page.
How is BCAX stock valued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge BCAX's intrinsic value.
Using relative valuations methods:
- BCAX may be undervalued based on its P/B ratio of 3.77x, relative to Biotechnology industry P/B ratio of 5.02x
You can access more valuation research on BCAX's stock here.
Is BCAX a healthy company?
Pros:
- BCAX has $414.80M in cash and short term investments. This is enough to cover its annual cash burn of $107.11M.
- BCAX has a low debt to equity ratio of 0.07.
- There are more short-term assets than short-term liabilities on the BCAX balance sheet.
- There are more short-term assets than long-term liabilities on the BCAX balance sheet.
- BCAX has cash burn of 107114000. It has enough cash and short-term investments to cover this for at least one year.
Do analysts think it's a good time to buy Bicara Therapeutics stock
Out of 8 Wall Street analysts who give recommendations on BCAX, the consensus analyst rating on Bicara Therapeutics is a Buy
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
Most Recent BCAX Analyst Upgrades/Downgrades
Tazeen Ahmad, a top 36% analyst from Bank of America initiates coverage on BCAX with a strong buy rating and announces their BCAX price target of $35.00, on Mar 25, 2026.
Jeet Mukherjee, a top 16% analyst from BTIG initiates coverage on BCAX with a strong buy rating and announces their BCAX price target of $28.00, on Jan 8, 2026.
Joseph Catanzaro, a top 22% analyst from Mizuho initiates coverage on BCAX with a hold rating and announces their BCAX price target of $18.00, on Dec 18, 2025.
You can dive deeper into what analysts are saying on the Bicara Therapeutics stock forecast page.
BCAX Momentum
Who is buying/selling BCAX?
In the last 12 months, executives and large shareholders at BCAX have bought more shares than they have sold.
Claire Mazumdar, Chief Executive Officer of BCAX, was the latest BCAX insider to buy. They bought $56,850.00 worth of BCAX stock on Apr 20, 2026.
Get more info about who owns BCAX stock here.
Can I rely on BCAX as an income stream?
No, Bicara Therapeutics doesn't provide an income stream by paying out dividends.
BCAX Social Trading Data
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Execute your BCAX purchase
You have two primary order types:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are generally the best for newer investors. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at a specific price limit, place a limit order.
Click the Open button and your broker will execute your order.
If you need more help buying stocks on eToro, click the helpful video below:
Step 6: Get key alerts regarding your BCAX position
Now that you own some BCAX shares, you'll want to keep up with your new investment.
Add BCAX to a watchlist to get the latest updates about your BCAX stock.
BCAX Feed
How to Buy Stock in Bicara Therapeutics
To reiterate, here are the 6 steps you need to take to buy Bicara Therapeutics stock right now:
- Figure out where to buy Bicara Therapeutics stock
- Sign up for a brokerage account
- Deposit money your brokerage account
- Analyze Bicara Therapeutics stock
- Execute your BCAX purchase
- Get key alerts regarding your BCAX position
If you need a place to buy stocks, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get updates on your investment in Bicara Therapeutics, click the button below.
Trending Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.